Tag Archives: WSJ Health Blog

Pharma: Trust Deficit or the Biggest Image Problem ever faced?

Posted on April 5, 2009 by xtello

It was Saturday afternoon; April 4th, to be precise. 7-time Tour de France winner and full-time cancer fighter: Lance Armstrong was in his born-state Texas, riding to give a speech in the PhRMA meeting in San Antonio. From his … Continue reading →

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged Acomplia, Advertising, Alzheimer, Alzheimer’s, AstraZeneca, Bioethics Blog, Chris MacDonald, CME, Code, Código, Continuing Medical Education, Covalence, Cuidado de la Salud, David Brennan, Déficit de confianza, Diabetes, Dick Clark, Direct to consumer, Dislipidemia, DTC, DTP Direct to patient, Educación Médica Contínua, Esclerosis Múltiple, Estados Unidos, Europa, Europe, FDA, Forbes, George Koroneos, Health Care, Insurance, JAMA, Jonathan Rockoff, Kathryn Metcalfe, Kevin Pho, Lance Armstrong, Merck, Multiple Sclerosis, No Free Lunch, Paul H. Rubin, Pfizer, PharmExec.com, PhRMA, PR, Promoción, Promotion, Public Relations, Publicidad, Regulatorio, Regulatory, Relaciones Públicas, Reputación, Reputation, San Antonio, Schering Plough, Seguro, Tour de France, Trust Deficit, Twitter, USA, Vioxx, WSJ Health Blog | 3 Comments